Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


17 Şubat 2022, Perşembe, 14:03 Haber Kaynağı: Çeşitli Haber Siteleri
BioNTech kurucusu Uğur Şahin'den Omicron aşısı açıklaması: Gecikecek
BioNTech’in CEO’su bilim insanı Prof. Uğur Şahin, Omicron varyantı için geliştirilecek aşının birkaç hafta ertelendiğini duyurdu.
https://www.cumhuriyet.com.tr/saglik/biontech-kurucusu-ugur-sahinden-omicron-asisi-aciklamasi-gecikecek-1908752

17 Şubat 2022, Perşembe, 13:32 Haber Kaynağı: Çeşitli Haber Siteleri
Uğur Şahin duyurdu: Omicron aşısı ertelendi
Pfizer ile birlikte corona virüsü aşısı geliştiren BioNTech’in kurucu ortaklarından 56 yaşındaki Uğur Şahin Alman Bild gazetesine konuştu… Bu yılın başında Omicron varyantına özel bir corona virüsü aşısı geliştirme kararı aldıklarını ve Mart ayının sonunda Omicron varyantına özel olan corona virüsü aşısının piyasaya çıkacağını duyuran Şahin bu projenin ertelendiğini duyurdu. Şahin, Omicron varyantına özel corona […]
https://www.sozcu.com.tr/2022/saglik/ugur-sahin-duyurdu-omicron-asisi-ertelendi-6958190/

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022
This report describes maternal mRNA vaccine effectiveness against COVID-19 hospitalizations among infants under 6 months of age.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=536908

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
This report describes how vaccine effectiveness against COVID-19-associated emergency department/urgent care visits and hospitalizations was higher after the third dose but decreased with time.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=529420

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022
This report describes genomic surveillance sequencing of COVID-19 variants by jurisdiction.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=525250

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
EARLY RELEASE: Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022
This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=529035

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022
This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=514039

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity - United States, August 29-October 30, 2021
This report describes COVID-19 vaccination coverage by sexual orientation and gender identity.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=510954

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
This report describes COVID-19 incidence and hospitalization rates during Omicron predominance in January 2022.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=508967

17 Şubat 2022, Perşembe, 12:06 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=492999